Fentanyl or Analogs Tied to More Than Half of All Opioid Deaths

Share this content:
Fentanyl or Analogs Tied to More Than Half of All Opioid Deaths
Fentanyl or Analogs Tied to More Than Half of All Opioid Deaths

TUESDAY, Oct. 31, 2017 (HealthDay News) -- Fentanyl was involved in more than half of opioid overdose deaths reported in the second half of 2016, according to a study published online Oct. 27 in Morbidity and Mortality Weekly Report.

Julie K. O'Donnell, Ph.D., from the U.S. Centers for Disease Control and Prevention (CDC) in Atlanta, and colleagues used data from 10 states participating in the CDC's Enhanced State Opioid Overdose Surveillance program to describe opioid overdose deaths from July through December 2016 that tested positive for fentanyl; fentanyl analogs; or U-47700, an illicit synthetic opioid.

The researchers found that fentanyl was detected in more than half (56.3 percent) of the 5,152 opioid overdose deaths in the 10 states. More than half of fentanyl-involved deaths (57 percent) also tested positive for other illicit drugs, such as heroin. Carfentanil, furanylfentanyl, and acetylfentanyl were the fentanyl analogs identified most frequently, and fentanyl analogs were present in more than 10 percent of opioid overdose deaths in four states.

"Expanded surveillance for opioid overdoses, including testing for fentanyl and fentanyl analogs, assists in tracking the rapidly changing illicit opioid market and informing innovative interventions designed to reduce opioid overdose deaths," conclude the authors.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

WHO: Vaccine Hesitancy a Major Global Health Threat

WHO: Vaccine Hesitancy a Major Global Health Threat

Percentage of U.S. children 19 to 35 months who have not been vaccinated has quadrupled since 2001

FDA Down to 5 Weeks of Funding to Review New Drug Applications

FDA Down to 5 Weeks of Funding to ...

Agency cannot accept new fees or applications until the shutdown is over

FDA Approves First Generic Version of Epilepsy Drug Sabril

FDA Approves First Generic Version of Epilepsy Drug ...

Generic equivalents held to same vigorous manufacturing standards as brand-name drugs

is free, fast, and customized just for you!




Already a member?

Sign In Now »